Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-24-006530
Filing Date
2024-11-14
Accepted
2024-11-14 09:38:25
Documents
2

Document Format Files

Seq Description Document Type Size
1 ARROWHEAD PHARMACEUTICALS, INC. p24-3166sc13g.htm SC 13G 57441
2 JOINT FILING AGREEMENT p24-3166exhibit99_1.htm EX-1 3099
  Complete submission text file 0000902664-24-006530.txt   62534
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Subject) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-48710 | Film No.: 241457851
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012
Business Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012 212-937-4975
Avoro Capital Advisors LLC (Filed by) CIK: 0001633313 (see all company filings)

EIN.: 271007403 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G